A Clinical Study on Causticum 200 Centesimal Potency in Primary Enuresis
NCT ID: NCT02154152
Last Updated: 2014-06-03
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
PHASE3
50 participants
INTERVENTIONAL
2014-05-31
2015-08-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
The Efficacy of Individualised Homeopathic Treatment on Constipation
NCT02411175
The Effect of Melatonin on Nocturnal Enuresis
NCT01575678
Chronic Constipation in Children Among School Children is Assuit University Children Hospital
NCT04110158
Rectal and Oral Omeprazole Treatment of Reflux Disease in Infants.
NCT00226044
Diagnosis of Functional Defecation Disorders in Childhood
NCT00230360
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
AIMS \& OBJECTIVES:
To assess and evaluate the efficacy of administering the Homoeopathic remedy Causticum 200 Centesimal potency based on Homoeopathic principles in management of Primary enuresis A total number of 30 cases will be selected after screening 50 cases as per the inclusion criteria from the Outpatient Department of Father Muller Homoeopathic Medical College for the study and will be followed for a period of one year.
Inclusion criteria:
1. Age group between 5-15 yrs
2. Both sexes are included
3. Patients with Primary enuresis will be Included
4. Patients with Nocturnal or Diurnal enuresis will be included
Exclusion criteria:
1 Patients with metabolic illness like Diabetes Mellitus or Diabetes Insipidus will be excluded 2. Congenital anomalies like horse shoe kidney, polycystic kidney will be excluded.
3\. Presence of Malignancy, Mental Retardation and Cerebral palsy will be excluded.
The case shall be analyzed and prescribed the remedy Causticum in 200 Centesimal potency, 4 globules once a week for 3 months with placebo to follow for the next few months and general management.
RESEARCH PLAN:
Purposive sampling will be followed in the study wherein patients who belong to the above category of Inclusion criteria will be taken up and subjected to screening so as to confirm the diagnosis of Enuresis.
Each patient will be treated for one year with Causticum 200C in the first 3 months along with placebo to follow and attended to, once a week. At each follow-up they will be assessed clinically for evaluating the improvement status.
The drug namely Causticum 200C potency will be ordered from Father Muller Homoeopathic Pharmaceutical division, which complies with the standards of Homoeopathic Pharmacopeia of India. The dosage shall be 4 globules prescribed once a week for 3 months with placebo to follow for the remaining period. This medicine shall be advised half an hour before food.
RESEARCH METHODOLOGY AND STATISTICS:
Criteria for deciding the Efficacy of Homoeopathic medicine Causticum200C shall be based on the following parameters:
1. Frequency of Enuresis
2. Odor of urine
3. Diurnal and Nocturnal urination
4. Modalities
PLAN FOR ANALYSIS: The collected data will be analyzed by paired 't' test to determine the efficiency.
RESEARCH HYPOTHESIS: There is significant improvement among Primary Enuresis cases in Paediatric age group after prescribing the Homoeopathic drug Causticum 200C.
NULL HYPOTHESIS: There is no significant improvement among Primary Enuresis cases in Paediatric age group after prescribing the Homoeopathic drug Causticum 200C.
ALTERNATIVE HYPOTHESIS: Significant variation in the above parameters before and after treatment.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
NA
SINGLE_GROUP
TREATMENT
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Homoeopathic Medicine Causticum
The drug namely Causticum 200C potency shall be administered as 4 globules, prescribed once a week for 3 months with placebo to follow for the remaining period.
Homoeopathic Medicine causticum 200c
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Homoeopathic Medicine causticum 200c
Other Intervention Names
Discover alternative or legacy names that may be used to describe the listed interventions across different sources.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Both sexes are included
* Patients with Primary enuresis will be Included
* Patients with Nocturnal or Diurnal enuresis will be included
Exclusion Criteria
* Congenital anomalies like horse shoe kidney, polycystic kidney will be excluded.
* Presence of Malignancy, Mental Retardation and Cerebral palsy will be excluded.
5 Years
15 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Father Muller Medical College
OTHER
Fr Muller Homoeopathic Medical College
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Jyoshna Shivaprasad
Dr Jyoshna Shivaprasad
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Jyoshna Shivaprasad, MD (Hom)
Role: PRINCIPAL_INVESTIGATOR
Father Muller Homoeopathic Medical College
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Father Muller Homoeopathic Medical College
Mangalore, Karnataka, India
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
enuresishmc
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.